Human papillomavirus types 16 and 18 and the prognosis of patients with stage I cervical cancer
OBJECTIVE: This study sought to evaluate the prevalence of human papillomavirus (HPV) types 16 and 18 in women with clinical stage IB cervical cancer treated by radical hysterectomy with pelvic lymphadenectomy as well as to establish a correlation between HPV type and cancer prognosis. METHODS: A...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier España
2013-06-01
|
| Series: | Clinics |
| Subjects: | |
| Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322013000600809 |
| _version_ | 1811318452570292224 |
|---|---|
| author | Rossana de Araújo Catão Zampronha Ruffo Freitas-Junior Eddie Fernando Candido Murta Márcia Antoniazi Michelin Aline Almeida Barbaresco Sheila Jorge Adad Amaurillo Monteiro de Oliveira Amanda B. Rassi Glória Jabur Bittar Oton |
| author_facet | Rossana de Araújo Catão Zampronha Ruffo Freitas-Junior Eddie Fernando Candido Murta Márcia Antoniazi Michelin Aline Almeida Barbaresco Sheila Jorge Adad Amaurillo Monteiro de Oliveira Amanda B. Rassi Glória Jabur Bittar Oton |
| author_sort | Rossana de Araújo Catão Zampronha |
| collection | DOAJ |
| description | OBJECTIVE: This study sought to evaluate the prevalence of human papillomavirus (HPV) types 16 and 18 in women with clinical stage IB cervical cancer treated by radical hysterectomy with pelvic lymphadenectomy as well as to establish a correlation between HPV type and cancer prognosis. METHODS: A single-center cohort study was conducted with 86 patients who had undergone radical hysterectomy for stage I cervical cancer. Prognostic factors and the presence of HPV 16 and 18 were analyzed using a polymerase chain reaction assay. A univariate analysis using Kaplan-Meier curves was conducted to estimate survival. RESULTS: The prevalence of HPV 16 in the study group was 65.3%, and the prevalence of HPV 18 was 33.3%. The prevalence of infection with both viruses was 26.9%. Overall survival at 5 years was 91% among women with HPV 18 and 96% among those without this virus type (p = 0.133). Among the women with HPV 16, the overall survival was 94%, whereas this rate was 96% among those without this virus type (p = 0.663). Disease-free survival was unaffected by the presence of HPV type 16 or 18. CONCLUSION: In the present study, despite the high prevalence of HPV types 16 and 18, the presence of these virus types did not affect the prognosis of patients with stage I cervical cancer who underwent radical hysterectomy. |
| first_indexed | 2024-04-13T12:26:29Z |
| format | Article |
| id | doaj.art-da962f19a4674b22971f26bff79cf81a |
| institution | Directory Open Access Journal |
| issn | 1807-5932 1980-5322 |
| language | English |
| last_indexed | 2024-04-13T12:26:29Z |
| publishDate | 2013-06-01 |
| publisher | Elsevier España |
| record_format | Article |
| series | Clinics |
| spelling | doaj.art-da962f19a4674b22971f26bff79cf81a2022-12-22T02:47:01ZengElsevier EspañaClinics1807-59321980-53222013-06-01686809814Human papillomavirus types 16 and 18 and the prognosis of patients with stage I cervical cancerRossana de Araújo Catão ZampronhaRuffo Freitas-JuniorEddie Fernando Candido MurtaMárcia Antoniazi MichelinAline Almeida BarbarescoSheila Jorge AdadAmaurillo Monteiro de OliveiraAmanda B. RassiGlória Jabur Bittar OtonOBJECTIVE: This study sought to evaluate the prevalence of human papillomavirus (HPV) types 16 and 18 in women with clinical stage IB cervical cancer treated by radical hysterectomy with pelvic lymphadenectomy as well as to establish a correlation between HPV type and cancer prognosis. METHODS: A single-center cohort study was conducted with 86 patients who had undergone radical hysterectomy for stage I cervical cancer. Prognostic factors and the presence of HPV 16 and 18 were analyzed using a polymerase chain reaction assay. A univariate analysis using Kaplan-Meier curves was conducted to estimate survival. RESULTS: The prevalence of HPV 16 in the study group was 65.3%, and the prevalence of HPV 18 was 33.3%. The prevalence of infection with both viruses was 26.9%. Overall survival at 5 years was 91% among women with HPV 18 and 96% among those without this virus type (p = 0.133). Among the women with HPV 16, the overall survival was 94%, whereas this rate was 96% among those without this virus type (p = 0.663). Disease-free survival was unaffected by the presence of HPV type 16 or 18. CONCLUSION: In the present study, despite the high prevalence of HPV types 16 and 18, the presence of these virus types did not affect the prognosis of patients with stage I cervical cancer who underwent radical hysterectomy.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322013000600809Human Papillomavirus (HPV)Cervical CancerPrognosisSurvival |
| spellingShingle | Rossana de Araújo Catão Zampronha Ruffo Freitas-Junior Eddie Fernando Candido Murta Márcia Antoniazi Michelin Aline Almeida Barbaresco Sheila Jorge Adad Amaurillo Monteiro de Oliveira Amanda B. Rassi Glória Jabur Bittar Oton Human papillomavirus types 16 and 18 and the prognosis of patients with stage I cervical cancer Clinics Human Papillomavirus (HPV) Cervical Cancer Prognosis Survival |
| title | Human papillomavirus types 16 and 18 and the prognosis of patients with stage I cervical cancer |
| title_full | Human papillomavirus types 16 and 18 and the prognosis of patients with stage I cervical cancer |
| title_fullStr | Human papillomavirus types 16 and 18 and the prognosis of patients with stage I cervical cancer |
| title_full_unstemmed | Human papillomavirus types 16 and 18 and the prognosis of patients with stage I cervical cancer |
| title_short | Human papillomavirus types 16 and 18 and the prognosis of patients with stage I cervical cancer |
| title_sort | human papillomavirus types 16 and 18 and the prognosis of patients with stage i cervical cancer |
| topic | Human Papillomavirus (HPV) Cervical Cancer Prognosis Survival |
| url | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322013000600809 |
| work_keys_str_mv | AT rossanadearaujocataozampronha humanpapillomavirustypes16and18andtheprognosisofpatientswithstageicervicalcancer AT ruffofreitasjunior humanpapillomavirustypes16and18andtheprognosisofpatientswithstageicervicalcancer AT eddiefernandocandidomurta humanpapillomavirustypes16and18andtheprognosisofpatientswithstageicervicalcancer AT marciaantoniazimichelin humanpapillomavirustypes16and18andtheprognosisofpatientswithstageicervicalcancer AT alinealmeidabarbaresco humanpapillomavirustypes16and18andtheprognosisofpatientswithstageicervicalcancer AT sheilajorgeadad humanpapillomavirustypes16and18andtheprognosisofpatientswithstageicervicalcancer AT amaurillomonteirodeoliveira humanpapillomavirustypes16and18andtheprognosisofpatientswithstageicervicalcancer AT amandabrassi humanpapillomavirustypes16and18andtheprognosisofpatientswithstageicervicalcancer AT gloriajaburbittaroton humanpapillomavirustypes16and18andtheprognosisofpatientswithstageicervicalcancer |